1. Home
  2. FSBW vs ESPR Comparison

FSBW vs ESPR Comparison

Compare FSBW & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBW
  • ESPR
  • Stock Information
  • Founded
  • FSBW 1936
  • ESPR 2008
  • Country
  • FSBW United States
  • ESPR United States
  • Employees
  • FSBW N/A
  • ESPR N/A
  • Industry
  • FSBW Banks
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSBW Finance
  • ESPR Health Care
  • Exchange
  • FSBW Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • FSBW 318.4M
  • ESPR 305.0M
  • IPO Year
  • FSBW 2012
  • ESPR 2013
  • Fundamental
  • Price
  • FSBW $37.11
  • ESPR $1.69
  • Analyst Decision
  • FSBW Hold
  • ESPR Buy
  • Analyst Count
  • FSBW 1
  • ESPR 7
  • Target Price
  • FSBW $44.00
  • ESPR $6.36
  • AVG Volume (30 Days)
  • FSBW 11.2K
  • ESPR 4.2M
  • Earning Date
  • FSBW 04-23-2025
  • ESPR 03-04-2025
  • Dividend Yield
  • FSBW 2.90%
  • ESPR N/A
  • EPS Growth
  • FSBW N/A
  • ESPR N/A
  • EPS
  • FSBW 4.36
  • ESPR N/A
  • Revenue
  • FSBW $139,150,000.00
  • ESPR $332,314,000.00
  • Revenue This Year
  • FSBW $9.22
  • ESPR $5.51
  • Revenue Next Year
  • FSBW $6.31
  • ESPR $1.42
  • P/E Ratio
  • FSBW $8.55
  • ESPR N/A
  • Revenue Growth
  • FSBW 0.09
  • ESPR 185.66
  • 52 Week Low
  • FSBW $30.64
  • ESPR $1.47
  • 52 Week High
  • FSBW $49.15
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • FSBW 43.88
  • ESPR 49.78
  • Support Level
  • FSBW $36.05
  • ESPR $1.47
  • Resistance Level
  • FSBW $37.81
  • ESPR $1.61
  • Average True Range (ATR)
  • FSBW 0.99
  • ESPR 0.12
  • MACD
  • FSBW 0.11
  • ESPR 0.02
  • Stochastic Oscillator
  • FSBW 48.25
  • ESPR 56.41

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking, and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: